348
Views
5
CrossRef citations to date
0
Altmetric
Psoriasis and Atopic Dermatitis

High rates of secondary non-adherence causes decreased efficacy of 0.1% topical tacrolimus in adult eczema patients: results from a multicenter clinical trial

ORCID Icon, , , , , , , , , , , , & ORCID Icon show all
Pages 129-134 | Received 21 Apr 2017, Accepted 13 Jun 2017, Published online: 18 Jul 2017
 

Abstract

Background: Patients tend to apply topical medications less frequently, in improper amounts. Not only frequency but also application amount may influence treatment outcome. However, studies on relationship between application amount and objective treatment outcome have rarely been conducted.

Objective: To assess efficacy of topical agent according to application amount in adult patients, using the finger-tip unit method.

Methods: The efficacy of 0.1% topical tacrolimus in adult patients with localised atopic dermatitis was assessed using EASI, TIS, IGA, and PGA scores at baseline, follow-up. Adherence in amount was evaluated after 2 weeks of treatment using the ratio of the actual amount applied to the expected amount applied (A/E).

Results: Twenty-seven patients (20.93%) used topical tacrolimus in proper amounts (A/E: 0.8–1.2). However, 86 patients (66.67%) underused topical tacrolimus; 16 (12.40%) patients overused topical tacrolimus. Decreases in EASI scores between baseline and 2 weeks of follow-up in each group (under-amount, proper amount, over-amount) were 1.64, 4.65 and 4.21, respectively. Treatment efficacy increased in accordance with application amount. Further, TIS, IGA, PGA, VAS for Itch and DLQI scores improved concomitantly, exhibiting similar tendencies.

Conclusion: Application amount of topical agent is important in increasing treatment efficacy in adult patients with atopic dermatitis.

Acknowledgements

IRB documentation was acquired from the institutional review board of the hospital.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The study was funded by Astellas Pharma Korea [Grant number AKR-PRT-2013-04].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.